(Q47310924)

English

Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity

scientific article published on 11 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Carine Gueugnon

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Fabienne Mougin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Marie-Laure Simon-Rigaud

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Jacques Regnard

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Véronique Nègre

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Gilles Dumoulin

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

publication date

11 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Applied Physiology, Nutrition, and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

37

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

672-679

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Effect of individualized weight-loss programmes on adiponectin, leptin and resistin levels in obese adolescent boys

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

The role of resistin as a regulator of inflammation: Implications for various human pathologies

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Ghrelin and PYY levels in adolescents with severe obesity: effects of weight loss induced by long-term exercise training and modified food habits

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adiponectin and adiponectin receptors

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Effect of obesity and insulin sensitivity on adiponectin isoform distribution.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Changes in adipocyte hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adiponectin: action, regulation and association to insulin sensitivity

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Effect of weight loss on high-molecular weight adiponectin in obese children.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Ratio of high-, medium-, and low-molecular weight serum adiponectin to the total adiponectin value in children

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Resistin is an inflammatory marker of atherosclerosis in humans.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adiponectin before and after weight loss in obese children

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Resistin concentrations before and after weight loss in obese children

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Plasma adiponectin complexes have distinct biochemical characteristics

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Adipose tissue-derived factors: impact on health and disease

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Post-translational modifications of adiponectin: mechanisms and functional implications.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1139%2FH2012-045

21 January 2018

Identifiers

10.1139/H2012-045

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22574715

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47310924&oldid=2151776112"